Obstructive Jaundice Diagnosis and Management

Clinical Presentation and Diagnosis

The combination of jaundice, pruritus, elevated bilirubin, and significantly elevated alkaline phosphatase represents a classic cholestatic pattern that strongly suggests biliary obstruction or cholestatic liver disease, as recommended by the European Association for the Study of the Liver 1, 2
Elevated alkaline phosphatase with conjugated hyperbilirubinemia signals cholestatic disease and potential biliary obstruction, according to the American Association for the Study of Liver Diseases 3
The presence of pruritus is highly characteristic of cholestasis, occurring when bile acids accumulate systemically due to impaired bile flow, as noted by the National Institute of Diabetes and Digestive and Kidney Diseases 4, 1
Laboratory findings of elevated alkaline phosphatase and bilirubin together indicate cholestasis with sensitivity of 65-95% and specificity of 71-97%, as reported by the American College of Gastroenterology 3
The biochemical pattern (elevated ALP >> transaminases) is the hallmark of obstructive or cholestatic processes, as stated by the European Association for the Study of the Liver 1, 2

Abdominal ultrasound as first-line imaging to exclude biliary obstruction is recommended, with sensitivity of 65-95% and specificity of 71-97%, according to the American Institute of Ultrasound in Medicine 3
Fractionation of bilirubin to confirm conjugated (direct) hyperbilirubinemia, which indicates hepatocellular injury or biliary obstruction, is suggested by the American Association for Clinical Chemistry 3
Additional liver function tests, including ALT, AST, GGT, albumin, and INR, to assess synthetic function and confirm cholestatic pattern, are recommended by the American Association for the Study of Liver Diseases 2, 3

If ultrasound shows dilated ducts, proceed to MRCP or ERCP depending on clinical suspicion for stones versus malignancy, as recommended by the American College of Radiology 3
If ultrasound is normal, consider intrahepatic cholestatic diseases, such as primary biliary cholangitis, primary sclerosing cholangitis, or drug-induced cholestasis, as noted by the European Association for the Study of the Liver 1, 2
Review medication history for hepatotoxic drugs, as suggested by the American College of Gastroenterology 2